bf/NASDAQ:APLS_icon.jpeg

COM:APELLIS

Apellis Pharmaceuticals, Inc.

  • Stock

USD

Last Close

27.75

22/11 21:00

Market Cap

4.54B

Beta: -

Volume Today

2.66M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
240.05K
-
68.68K
71.39%
8.14M
-
51M
526.30%
116.04M
127.53%
average payables
552.70K
-
1.61M
192.11%
2.51M
55.61%
3.11M
23.60%
6.96M
124.11%
9.31M
33.75%
8.42M
9.55%
12.69M
50.77%
27.13M
113.70%
37.43M
37.98%
average receivables
266.53K
-
232.93K
12.61%
5.05M
-
8.91M
76.48%
107.08M
1,101.17%
book value per share
0.25
-
0.73
192.42%
1.93
164.48%
1.32
31.97%
10.74
716.49%
2.96
72.44%
0.55
81.41%
2.72
394.77%
2.35
13.53%
2.26
3.96%
capex per share
-0.00
-
-0.03
-
-0.07
165.10%
-0.01
81.89%
-0.02
55.19%
capex to depreciation
-3.02
-
-7.06
-
-8.51
20.48%
-0.74
91.31%
-1.02
38.63%
capex to operating cash flow
0.00
-
0.01
-
0.03
321.25%
0.00
94.20%
0.00
51.45%
capex to revenue
-0.02
-
-0.02
23.40%
-0.02
21.94%
cash per share
0.26
-
0.75
186.30%
1.99
164.29%
1.37
30.94%
12.66
821.45%
3.24
74.41%
5.66
74.55%
11.68
106.44%
8.30
28.93%
7.34
11.53%
days of inventory on hand
1.14K
-
5.55K
385.59%
913.04
83.55%
days payables outstanding
26.34
-
29.26
11.09%
10.60
63.79%
123.52
1,065.78%
1.19K
860.90%
2.42K
103.76%
234.03
90.32%
days sales outstanding
55.40
-
37.39
32.50%
205.72
450.14%
debt to assets
0.14
-
0.13
8.30%
0.40
203.62%
0.39
2.53%
0.24
39.37%
0.15
37.81%
0.12
20.44%
debt to equity
0.18
-
0.17
5.18%
4.59
2,630.65%
1.85
59.75%
1.06
42.70%
0.66
37.30%
0.48
27.92%
dividend yield
earnings yield
-0.02
-
-0.04
172.33%
-0.18
331.16%
-0.11
41.69%
-0.17
58.58%
-0.18
4.87%
-0.16
8.50%
-0.08
50.67%
-0.19
133.11%
-0.17
10.26%
enterprise value
249.09M
-
240.22M
3.56%
217.84M
9.32%
228.98M
5.11%
151.75M
33.73%
568.26M
274.48%
1.71B
201.01%
4.11B
140.36%
3.56B
13.37%
3.45B
3.20%
-258.15M
107.49%
enterprise value over ebitda
-61.91
-
-21.28
65.63%
34.04
259.97%
-8.39
124.65%
-3.00
64.27%
-4.54
51.50%
-6.05
33.11%
-19.63
224.61%
-6.68
65.96%
-5.90
11.73%
0.47
107.99%
ev to operating cash flow
-72.31
-
-24.15
66.60%
-11.55
52.16%
-8.81
23.78%
-3.26
63.02%
-4.33
32.95%
-8.10
87.10%
-25.62
216.21%
-6.32
75.31%
-6.71
6.11%
0.43
106.47%
ev to sales
16.40
-
53.50
226.20%
45.71
14.57%
-0.70
101.54%
free cash flow per share
-0.19
-
-0.55
189.34%
-1.04
89.19%
-1.44
37.90%
-3.36
133.73%
-2.41
28.18%
-3.42
41.75%
-2.21
35.46%
-6.68
202.79%
-6.86
2.57%
free cash flow yield
-0.01
-
-0.04
189.34%
-0.07
89.19%
-0.10
37.90%
-0.15
51.12%
-0.18
18.16%
-0.11
38.94%
-0.04
65.45%
-0.14
266.32%
-0.13
6.22%
graham net net
0.24
-
0.72
201.16%
1.81
153.12%
1.17
35.30%
10.27
775.47%
2.46
76.07%
-0.05
101.98%
1.62
3,423.36%
0.39
75.72%
0.13
65.77%
graham number
1.11
-
3.13
182.19%
10.57
237.69%
6.66
37.02%
29.81
347.51%
12.49
58.09%
7.85
37.17%
16.76
113.54%
21.64
29.08%
21.01
2.91%
income quality
0.87
-
0.92
6.04%
0.41
56.03%
0.96
136.49%
0.91
4.71%
1.03
12.68%
0.69
32.68%
0.47
32.84%
0.75
62.14%
0.79
4.41%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
523.83
-
-50.91
109.72%
-54.50
7.06%
-7.14
86.90%
-40.50
467.31%
-18.23
55.00%
18.51
201.54%
interest debt per share
1.90
-
0.54
71.33%
2.61
380.04%
5.42
107.94%
2.65
51.20%
1.93
26.95%
inventory turnover
0.32
-
0.07
79.41%
0.40
507.97%
invested capital
0.18
-
0.17
5.18%
4.59
2,630.65%
1.85
59.75%
1.06
42.70%
0.66
37.30%
0.48
27.92%
market cap
253.84M
-
253.84M
0%
253.84M
0%
253.84M
0%
301.00M
18.58%
717.48M
138.37%
1.91B
165.57%
4.30B
125.63%
3.99B
7.16%
3.89B
2.62%
net current asset value
4.51M
-
13.17M
191.70%
34.84M
164.65%
23.73M
31.90%
148.83M
527.17%
159.88M
7.43%
18.08M
88.69%
161.18M
791.51%
140.94M
12.55%
129.18M
8.35%
172.12M
33.24%
net debt to ebitda
1.18
-
1.21
2.05%
-5.63
566.20%
0.91
116.20%
2.95
223.65%
1.19
59.55%
0.69
42.23%
0.90
30.27%
0.81
10.16%
0.75
6.88%
0.47
37.23%
net income per share
-0.22
-
-0.60
172.33%
-2.57
331.16%
-1.50
41.69%
-3.68
145.28%
-2.34
36.26%
-4.98
112.40%
-4.59
7.84%
-8.84
92.68%
-8.68
1.86%
operating cash flow per share
-0.19
-
-0.55
188.76%
-1.04
89.57%
-1.44
37.90%
-3.36
133.73%
-2.41
28.18%
-3.39
40.63%
-2.14
37.07%
-6.67
212.40%
-6.84
2.47%
payables turnover
13.86
-
12.47
9.99%
34.45
176.16%
2.96
91.42%
0.31
89.59%
0.15
50.92%
1.56
933.33%
receivables turnover
6.59
-
9.76
48.15%
1.77
81.82%
research and ddevelopement to revenue
1.20
-
6.32
428.41%
5.13
18.80%
0.97
81.16%
return on tangible assets
-0.76
-
-0.75
1.02%
-1.22
61.57%
-0.99
18.85%
-0.28
71.68%
-0.63
123.69%
-0.80
27.06%
-0.36
54.89%
-0.85
135.75%
-0.86
1.35%
-0.67
21.87%
revenue per share
3.33
-
0.79
76.36%
1.00
27.27%
roe
-0.88
-
-0.82
6.87%
-1.33
63.02%
-1.14
14.28%
-0.34
69.96%
-0.79
131.29%
-9.05
1,042.71%
-1.69
81.37%
-3.76
122.84%
-3.84
2.19%
-2.72
29.21%
roic
-0.89
-
-0.82
7.93%
-0.57
30.28%
-1.15
100.48%
-0.29
74.62%
-0.68
132.86%
-1.42
110.09%
-0.36
74.89%
-1.25
249.04%
-1.97
57.70%
-1.91
2.84%
sales general and administrative to revenue
0.56
-
2.66
377.50%
3.67
38.38%
1.37
62.79%
shareholders equity per share
0.25
-
0.73
192.42%
1.93
164.48%
1.32
31.97%
10.74
716.49%
2.96
72.44%
0.55
81.41%
2.72
394.77%
2.35
13.53%
2.26
3.96%
stock based compensation to revenue
0.18
-
1.06
486.43%
1.21
13.75%
tangible asset value
4.52M
-
13.22M
192.42%
34.98M
164.48%
23.79M
31.97%
148.94M
525.96%
160.97M
8.08%
34.23M
78.74%
204.56M
497.60%
198.66M
2.88%
169.87M
14.49%
194.52M
14.51%
tangible book value per share
0.25
-
0.73
192.42%
1.93
164.48%
1.32
31.97%
10.74
716.49%
2.96
72.44%
0.55
81.41%
2.72
394.77%
2.35
13.53%
2.26
3.96%
working capital
4.51M
-
13.17M
191.70%
34.84M
164.65%
23.73M
31.90%
175.46M
639.41%
185.41M
5.67%
307.34M
65.76%
788.87M
156.67%
692.20M
12.25%
551.91M
20.27%
518.74M
6.01%

All numbers in USD (except ratios and percentages)